PeptideDB

Caroxazone

CAS No.: 18464-39-6

Caroxazone is an antidepressant drug, monoamine oxidase inhibitor (MAOI) that is irreversible and nonselective meanwhile
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Caroxazone is an antidepressant drug, monoamine oxidase inhibitor (MAOI) that is irreversible and nonselective meanwhile.
molecular weight 206.2
Molecular formula C10H10N2O3
CAS 18464-39-6
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Moretti A, Caccia C, Martini A, Bonollo L, Amico A, Sega R, Nicolella V, Nicolis FB. Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers. Br J Clin Pharmacol. 1981 May;11(5):511-5. PubMed PMID: 7272163; PubMed Central PMCID: PMC1401585. 2. Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man. Br J Clin Pharmacol. 1981 Jun;11(6):611-5. PubMed PMID: 7272178; PubMed Central PMCID: PMC1402186. 3. Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A, Braibanti E. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man. Br J Clin Pharmacol. 1981 Jun;11(6):605-10. PubMed PMID: 7272177; PubMed Central PMCID: PMC1402193. 4. Tannhauser SL, Elsner J, Tannhauser M, Barros HM, Tannhauser MA. Effects of phenylethylamine on rat locomotor behavior and avoidance learning. Braz J Med Biol Res. 1989;22(2):213-24. PubMed PMID: 2790290.